Back to first-pass browser

First-pass extracted concept

biomolecule-driven smart drug delivery systems

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

These systems are described as smart materials that convert drug delivery from a passive process into an active, programmable, and highly specific intervention. They sense pathophysiological cues or external triggers and respond accordingly.

Source 1DOIPubMed

Resources required

The abstract states that these systems are constructed from or functionalized with biological macromolecules such as nucleic acids, peptides, proteins, and polysaccharides. They also require a trigger-responsive design matched to endogenous or exogenous stimuli.

Source 1DOIPubMed

What problem it solves

The review says these intelligent systems are being designed to overcome critical biological barriers and enhance therapeutic efficacy. They aim to improve control and specificity of delivery.

Source 1DOIPubMed

What it does not solve

The abstract explicitly notes unresolved challenges in biocompatibility, manufacturing scalability, and regulatory navigation. It does not claim these challenges are solved.

Source 1DOIPubMed

Alternatives

The abstract contrasts these systems with passive drug delivery. It also distinguishes multiple biomolecular architecture classes rather than naming a single dominant platform.

Source 1DOIPubMed

Evidence Snippets

Biomolecule-driven smart materials represent a paradigm shift in pharmacology, transitioning drug delivery from a passive process to an active, programmable, and highly specific intervention.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1application overviewsupports2025Source 1DOIPubMed

Key therapeutic applications discussed for biomolecule-driven smart drug delivery systems include oncology, inflammatory diseases, and gene therapy.

Claim 2challenge overviewsupports2025Source 1DOIPubMed

Biocompatibility, manufacturing scalability, and regulatory navigation are identified as major challenges for translating biomolecule-driven smart drug delivery systems.

Claim 3field overviewsupports2025Source 1DOIPubMed

Biomolecule-driven smart materials are described as shifting drug delivery from a passive process to an active, programmable, and highly specific intervention.

Claim 4mechanism overviewsupports2025Source 1DOIPubMed

Biomolecule-driven smart drug delivery systems are engineered to sense and respond to specific pathophysiological cues or external triggers.

Claim 5trigger taxonomysupports2025Source 1DOIPubMed

The review categorizes stimuli-responsive actuation by endogenous triggers including pH, redox, enzymes, and ROS, and exogenous triggers including temperature, light, and magnetic fields.